Back to search

Peptide record

TPDB10276

Brevinin-1BLa Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard

24 amino acids

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB10276

Peptide_Name

Brevinin-1BLa

Activity

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity

Activity_category_statistics

Anti-infective peptides Cancer-related peptides Toxicity and safety peptides

Database_Source

AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0

Sequence_Type

standard

Has_Modification No

Description A 24-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.

Sequence

FLPIIAGAAAKVVQKIFCAISKKC

FASTA

>TPDB10276|Antibacterial;Anticancer;Antifungal;Antiparasitic;Antiviral;Hemolysis;Toxicity|length=24
FLPIIAGAAAKVVQKIFCAISKKC

Formula C118H199N29O27S2

Absent Amino Acids RNDEHMTWY

Common Amino Acids A

Mass 2520.18

PI 10.17

Basic Residues 4

Acidic Residues 0

Hydrophobic Residues 14

Net Charge +4

Boman Index -0.12

Hydrophobicity 1.163

Aliphatic Index 126.25

Half Life

Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 125

Absorbance 280nm 4.96

Polar Residues 4

number

Amino Acid Distribution

A: 5 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 1 G: 1 H: 0 I: 4 L: 1 K: 4 M: 0 F: 2 P: 1 S: 1 T: 0 W: 0 Y: 0 V: 2

Length

Formula

C118H199N29O27S2

Mass

2520.18

10.17

Net Charge

Boman Index

-0.12

Hydrophobicity

1.163

C_terminal_Modification

Free

Chirality

Linear_or_Cyclic

Not Available

N_terminal_Modification

Free

Nature

Antibacterial

Origin

North America, leopard frog, Lithobates blairi

Evidence 1 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 25 µM

Target

Target Organism Escherichia coli

Source & Reference

Database Source dbAMP DRAMP

Other

Source Activity Label	Source Definition
Antibacterial	dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 2 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 3 µM

Target

Target Organism Staphylococcus aureus

Source & Reference

Database Source dbAMP DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 3 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 3 µM

Target

Target Organism Candida albicans

Source & Reference

Database Source dbAMP DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 4 Activity

Activity

Activity Raw

Not Available

Detail Source Activity Anticancer

Target

Cancer Type Not Available

Cell Line Not Available

Tissue Affected Not Available

Assay & Model

Assay Not Available

Testing Time Not Available

Source & Reference

Database Source CancerPPD 2.0 dbACP SATPdb

Source CancerPPD2

Year 2009

Other

Source Activity Label	Source Definition
Anticancer	CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.

Evidence 5 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 25 µM

Target

Target Organism Escherichia coli

Source & Reference

Database Source dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label	Source Definition
Antifungal	dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 6 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 3 µM

Target

Target Organism Staphylococcus aureus

Source & Reference

Database Source dbAMP DRAMP CAFPdb Antifungipept

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 7 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 3 µM

Target

Target Organism Candida albicans

Source & Reference

Database Source dbAMP DRAMP CAFPdb Antifungipept

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 8 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 25 µM

Target

Target Organism Escherichia coli

Source & Reference

Database Source DRAMP

Other

Source Activity Label	Source Definition
Antiparasitic	DRAMP antiparasitic activity supported by activity records against parasitic targets.

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 9 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 3 µM

Target

Target Organism Staphylococcus aureus

Source & Reference

Database Source DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 10 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 3 µM

Target

Target Organism Candida albicans

Source & Reference

Database Source DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 11 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 25 µM

Target

Target Organism Escherichia coli

Source & Reference

Database Source DRAMP

Other

Source Activity Label	Source Definition
Antiviral	DRAMP antiviral activity supported by activity records against viral targets.

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 12 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 3 µM

Target

Target Organism Staphylococcus aureus

Source & Reference

Database Source DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 13 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 3 µM

Target

Target Organism Candida albicans

Source & Reference

Database Source DRAMP

Other

Evidence Text

Activity against E. coli (MIC 25 uM), S. aureus (MIC 3 uM), C. albicans (MIC 3 uM), cancer cells HepG2 (LC50 11 uM).

Evidence 14 Activity

Activity

Activity Endpoint LC50

Detail Source Activity Hemolysis

Activity Measurement 16 µM

Hemolysis Raw

[Ref.19254736] LC50=16 µM against human red blood cells

Target

RBC Target human red blood cells

Source & Reference

Database Source Hemolytik APD_complete APD_hemolytic PD_Hemolysis

Source DRAMP4

Reference

Toxicon. 2009 Jun 53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.

Other

Source Activity Label	Source Definition
Hemolysis	APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.

Evidence 15 Activity

Activity

Activity Endpoint 50% Hemolysis

Detail Source Activity Toxicity

Activity Measurement 10-16 µM

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

50% Hemolysis | 10-16 | µM | target cell: Human erythrocytes

Target

Target Cell Human erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Evidence 16 Activity

Activity

Activity Endpoint LC50

Detail Source Activity Toxicity

Activity Measurement 16 µM

Toxicity Type Hemolytic

Toxicity Raw

Hemolytic_activity: [Ref.19254736] LC50=16 µM against human red blood cells

Target

Target Cell erythrocytes

Source & Reference

Database Source NA

Source Database DRAMP

Reference

Toxicon. 2009 Jun 53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.

Evidence 17 Hemolysis

Activity

Activity Measurement 16 µM

Activity Endpoint LC50

Hemolysis Raw

[Ref.19254736] LC50=16 µM against human red blood cells

Detail Source Activity Hemolysis

Target

RBC Target human red blood cells

Source & Reference

source APD_complete APD_hemolytic HemoPI PD_Hemolysis

Reference

Toxicon. 2009 Jun 53(7-8):699-705. doi: 10.1016/j.toxicon.2009.02.018.

Source DRAMP4

Database Source APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label	Source Definition
Hemolysis	APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.